FA
VIVO

FDx Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

FDx Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-19,367
Closed -$343K – 964
2014
Q3 		$343K Sell
19,367
-437
-2% -$8.59K 0.02% 738
2014
Q2 		$409K Hold
19,804
– – 0.03% 655
2014
Q1 		$432K Hold
19,804
– – 0.04% 483
2013
Q4 		$525K Sell
19,804
-318
-2% -$7.82K 0.05% 344
2013
Q3 		$476K Sell
20,122
-201
-1% -$4.69K 0.06% 310
2013
Q2 		$437K Buy
+20,323
New +$438K 0.06% 289

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FDx Advisors's VIVO Position: Q4 2014 in Review

FDx Advisors sold out of Meridian Bioscience Inc (VIVO) in Q4 2014, closing a stake of 19,367 shares — an estimated $343K sold.

FDx Advisors first reported a position in VIVO in Q2 2013 and held it in 6 quarters. The position peaked at $525K in Q4 2013. 160 funds tracked by Wall St. Rank hold VIVO as of Q4 2014.

  • FDx Advisors reported no remaining Meridian Bioscience Inc position as of Q4 2014 after selling out during the quarter.
  • FDx Advisors sold 19,367 Meridian Bioscience Inc shares in Q4 2014, an estimated $343K.
  • FDx Advisors first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 6 quarters.
  • FDx Advisors's Meridian Bioscience Inc position peaked at $525K in Q4 2013.
  • 160 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2014.

Based on FDx Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.